These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1637803)

  • 41. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants.
    Toni C; Perugi G; Frare F; Mata B; Akiskal HS
    Acta Psychiatr Scand; 2004 Aug; 110(2):130-7. PubMed ID: 15233713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative trial of valproate sodium and clonazepam in chronic epilepsy.
    Shakir RA; Nanda RN; Lambie DG; Johnson RH
    Arch Neurol; 1979 May; 36(5):301-4. PubMed ID: 375883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The anticonvulsant effect of sodium valproate and clonazepam in the management of intractable epilepsy.
    Lance JW; Anthony M
    Trans Am Neurol Assoc; 1976; 101():200-4. PubMed ID: 800689
    [No Abstract]   [Full Text] [Related]  

  • 45. Interactive case conference. First episode: depression and panic disorder.
    Dunner DL
    CNS Spectr; 2005 Sep; 10(9):696-7. PubMed ID: 16142209
    [No Abstract]   [Full Text] [Related]  

  • 46. Attenuation of carbon dioxide-induced panic after clonazepam treatment.
    Pols H; Zandbergen J; de Loof C; Griez E
    Acta Psychiatr Scand; 1991 Dec; 84(6):585-6. PubMed ID: 1792935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
    Benazzi F
    J Psychopharmacol; 1997; 11(2):190-1. PubMed ID: 9208383
    [No Abstract]   [Full Text] [Related]  

  • 48. Sodium valproate in the treatment of cerebellar disorders.
    Neophytides AN; Teychenne PF; Pfeiffer RF; Calne DB
    Can J Neurol Sci; 1979 Nov; 6(4):455-7. PubMed ID: 120757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of treatment with imipramine and clonazepam on an animal model of panic disorder.
    Shekhar A
    Biol Psychiatry; 1994 Dec; 36(11):748-58. PubMed ID: 7858071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pramipexole augmentation in panic with agoraphobia.
    Marazziti D; Presta S; Pfanner C; Dell'Osso L; Cassano GB
    Am J Psychiatry; 2001 Mar; 158(3):498-9. PubMed ID: 11230001
    [No Abstract]   [Full Text] [Related]  

  • 51. Correlates of therapeutic response in panic disorder presenting with palpitations: heart rate variability, sleep, and placebo effect.
    Baker B; Khaykin Y; Devins G; Dorian P; Shapiro C; Newman D
    Can J Psychiatry; 2003 Jul; 48(6):381-7. PubMed ID: 12894612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of severe action myoclonus.
    Obeso JA; Artieda J; Rothwell JC; Day B; Thompson P; Marsden CD
    Brain; 1989 Jun; 112 ( Pt 3)():765-77. PubMed ID: 2499399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonazepam for the treatment of panic disorder.
    Nardi AE; Machado S; Almada LF; Paes F; Silva AC; Marques RJ; Amrein R; Freire RC; Martin-Santos R; Cosci F; Hallak JE; Crippa JA; Arias-Carrión O
    Curr Drug Targets; 2013 Mar; 14(3):353-64. PubMed ID: 23256724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

  • 55. Sodium valproate and clonazepam for epilepsy.
    Drug Ther Bull; 1975 Dec; 13(25):97-8. PubMed ID: 1104300
    [No Abstract]   [Full Text] [Related]  

  • 56. An open clinical trial of clonazepam in the treatment of patients with recurrent panic attacks.
    Beaudry P; Fontaine R; Chouinard G; Annable L
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):589-92. PubMed ID: 3911285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Combination of sodium valproate and clonazepam in the treatment of symptomatic West syndrome and Lennox syndrome].
    Oki J; Tasaki T; Kusunoki Y; Cho K; Yoshioka H
    No To Hattatsu; 1985 Jan; 17(1):37-43. PubMed ID: 3918550
    [No Abstract]   [Full Text] [Related]  

  • 58. Early carbon dioxide challenge test may predict clinical response in panic disorder.
    Valença AM; Nardi AE; Nascimento I; Zin WA; Lopes FL; Mezzasalma MA; Versiani M
    Psychiatry Res; 2002 Nov; 112(3):269-72. PubMed ID: 12450637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Agitated depression, panic anxiety, and clonazepam.
    Kahn JP
    J Clin Psychiatry; 2006 Dec; 67(12):2034. PubMed ID: 17194291
    [No Abstract]   [Full Text] [Related]  

  • 60. A case of anorexia nervosa associated with epileptic seizures showing favorable responses to sodium valproate and clonazepam.
    Tachibana N; Sugita Y; Teshima Y; Hishikawa Y
    Jpn J Psychiatry Neurol; 1989 Mar; 43(1):77-84. PubMed ID: 2500550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.